Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection (ECOSPORIII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03183128
Recruitment Status : Completed
First Posted : June 9, 2017
Last Update Posted : July 2, 2021
Information provided by (Responsible Party):
Seres Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 3, 2020
Actual Study Completion Date : September 29, 2020
Certification/Extension First Submitted : June 21, 2021